Comparison of Cervical Cerclage by Vaginal and by Laparoscopic Transabdominal Routes in the Periconceptional Period

NCT ID: NCT06788873

Last Updated: 2025-01-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-05-15

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to compare two different surgical techniques of performing elective cervical cerclage in the prevention of preterm delivery, both of which are already widely used in common clinical practice: elective cervical cerclage by the vaginal route and laparoscopic transabdominal elective cervical cerclage.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

For the purpose of this study, no study-specific visits are planned. Data will be collected in a pseudo-anonymized manner, assigning each participant a sequence number.

For patients who undergo elective vaginal cervical cerclage at the division of Obstetrics and Prenatal Age Medicine or laparoscopic cerclage at the division of Gynecology and Human Reproductive Pathophysiology, the normal care pathway does not include additional follow-up visits for outpatient follow-up visits.

Regarding data collected in the past as part of the normal care pathway, patients will be asked to give informed consent in the context of a follow-up visit at which a practice staff member will be present.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cerclage, Cervical

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Single pregnancy and vaginal cerclage

Participants with a single pregnancy and unfavorable obstetrical history (at least two preterm deliveries or abortions in the 2nd trimester of pregnancy) who underwent elective cervical cerclage vaginally between 01/01/2002 and 31/12/2020

Data comparison

Intervention Type OTHER

For each participant, information will be collected on:

* Gestational age at the time the cerclage was performed
* Parity
* Age
* BMI
* Ethnicity
* Number of preterm deliveries
* Gestational age of previous preterm deliveries
* Previous uterine and/or cervix surgery (previous cerclage, conization, metroplasty, or other)
* Type of cerclage performed
* Operative times
* Days of hospitalization
* Surgical complications
* Gestational age at the time of delivery
* Mode of delivery (spontaneous, operative or cesarean)
* Infant's weight at birth
* Apgar at 1' and 5' minute
* Ph newborn
* Possible admission to neonatal intensive care unit.

No pregnancy and laparoscopic transabdominal cervical cerclage

Non-pregnant participants (with the same anamnestic characteristics as the first group) who underwent elective transabdominal laparoscopic cervical cerclage in the periconceptional period.

Data comparison

Intervention Type OTHER

For each participant, information will be collected on:

* Gestational age at the time the cerclage was performed
* Parity
* Age
* BMI
* Ethnicity
* Number of preterm deliveries
* Gestational age of previous preterm deliveries
* Previous uterine and/or cervix surgery (previous cerclage, conization, metroplasty, or other)
* Type of cerclage performed
* Operative times
* Days of hospitalization
* Surgical complications
* Gestational age at the time of delivery
* Mode of delivery (spontaneous, operative or cesarean)
* Infant's weight at birth
* Apgar at 1' and 5' minute
* Ph newborn
* Possible admission to neonatal intensive care unit.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Data comparison

For each participant, information will be collected on:

* Gestational age at the time the cerclage was performed
* Parity
* Age
* BMI
* Ethnicity
* Number of preterm deliveries
* Gestational age of previous preterm deliveries
* Previous uterine and/or cervix surgery (previous cerclage, conization, metroplasty, or other)
* Type of cerclage performed
* Operative times
* Days of hospitalization
* Surgical complications
* Gestational age at the time of delivery
* Mode of delivery (spontaneous, operative or cesarean)
* Infant's weight at birth
* Apgar at 1' and 5' minute
* Ph newborn
* Possible admission to neonatal intensive care unit.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with unfavorable obstetric history, i.e., at least two previous preterm deliveries or second-trimester abortions who underwent elective prophylactic cervical cerclage (vaginal or laparoscopic) between 01/01/2002 and 31/12/2020
* Age ≥18 years
* Obtaining informed consent form
* Availability of clinical-demographic data

Exclusion Criteria

* Multiple pregnancy
Minimum Eligible Age

18 Years

Maximum Eligible Age

44 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Elisa Montaguti, MD

Role: PRINCIPAL_INVESTIGATOR

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Bologna, Bologna, Italy

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Elisa Montaguti, MD

Role: CONTACT

0512144369

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Elisa Montaguti, MD

Role: primary

0512144369

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ROUND-21

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Cerclage for Twins With Short Cervix
NCT03077633 WITHDRAWN PHASE2/PHASE3
Outpatient Foley Cervix Priming
NCT02842879 COMPLETED NA